In response to an editorial suggesting that trials using invasive placebos should be excluded from Cochrane Reviews, David Kallmes and co-authors write their own editorial with an opposing view. Here, David Kallmes, from the Mayo Clinic in Rochester USA, describes why he thinks trials using invasive controls should be included in Cochrane Reviews.

Read the Editorial here.